Factors Related to Intracranial Hematoma Formation in Patients Receiving Tissue‐Type Plasminogen Activator forAcute Ischemic Stroke

No abstract is available for this paper.

• Publication year

  1994

• Venue

  Stroke

• Publication date

  1994-02-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1161/01.STR.25.2.291PMID 8303734
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Neuroradiologic evaluation of patients with acute stroke treated with recombinant tissue plasminogen activator. The rt-PA Acute Stroke Study Group.

  1993cited by this paper
• ISIS-3: a randomised comparison of streptokinase vs tissue plasminogen activator vs anistreplase and of aspirin plus heparin vs aspirin alone among 41 299 cases of suspected acute myocardial infarction

  1992cited by this paper
• Clinical risks of thrombolytic therapy.

  1992cited by this paper
• Safety and Efficacy of Intravenous Tissue Plasminogen Activator and Heparin in Acute Middle Cerebral Artery Stroke

  1992cited by this paper
• Urgent Therapy for Stroke: Part II. Pilot Study of Tissue Plasminogen Activator Administered 91-180 Minutes From Onset

  1992cited by this paper
• Urgent Therapy for Stroke: Part I. Pilot Study of Tissue Plasminogen Activator Administered Within 90 Minutes

  1992cited by this paper
• Intracranial hemorrhage in association with thrombolytic therapy: incidence and clinical predictive factors.

  1992cited by this paper
• Ischemic stroke and intracranial hemorrhage following thrombolytic therapy for acute myocardial infarction: a risk-benefit analysis.

  1992cited by this paper
• The risk of stroke in patients with acute myocardial infarction after thrombolytic and antithrombotic treatment. Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico II (GISSI-2), and The International Study Group.

  1992cited by this paper
• Intracranial hemorrhage after coronary thrombolysis with tissue plasminogen activator.

  1992cited by this paper
• Intracranial hemorrhage after thrombolytic therapy: a therapeutic conflict.

  1992cited by this paper
• Recombinant tissue plasminogen activator in acute thrombotic and embolic stroke

  1992cited by this paper
• The risk of stroke in patients with acute myocardial infarction after thrombolytic and antithrombotic treatment: Maggioni AP, Franzosi MG, Santoro E, et al N Engl J Med 327:1–6 Jul 1992

  1992cited by this paper
• ISIS-3: a randomised comparison of streptokinase vs tissue plasminogen activator vs anistreplase and of aspirin plus heparin vs aspirin alone among 41,299 cases of suspected acute myocardial infarction. ISIS-3 (Third International Study of Infarct Survival) Collaborative Group.

  1992cited by this paper
• Cerebrovascular events after myocardial infarction: analysis of the GISSI trial. Gruppo Italiano per lo Studio della Streptochinasi nell'Infarto Miocardico (GISSI).

  1991cited by this paper
• Hemorrhagic events during therapy with recombinant tissue-type plasminogen activator, heparin, and aspirin for acute myocardial infarction. Results of the Thrombolysis in Myocardial Infarction (TIMI), Phase II Trial.

  1991cited by this paper
• Intracranial Hemorrhage Following Thrombolytic Therapy for Acute Myocardial Infarction

  1991cited by this paper
• Intracerebral hemorrhage, cerebral infarction, and subdural hematoma after acute myocardial infarction and thrombolytic therapy in the Thrombolysis in Myocardial Infarction Study. Thrombolysis in Myocardial Infarction, Phase II, pilot and clinical trial.

  1991cited by this paper
• Older age and elevated blood pressure are risk factors for intracerebral hemorrhage after thrombolysis.

  1991cited by this paper
• MEDICAL SCIENCE: GISSI-2: A factorial randomised trial of alteplase versus streptokinase and heparin versus no heparin among 12 490 patients with acute myocardial infarction

  1990cited by this paper
• Fatal Streptokinase-Induced Intracerebral Haemorrhage in Cerebral Amyloid Angiopathy

  1990cited by this paper
• Intracranial hemorrhage after use of tissue plasminogen activator for coronary thrombolysis.

  1990cited by this paper
• In-hospital mortality and clinical course of 20,891 patients with suspected acute myocardial infarction randomised between alteplase and streptokinase with or without heparin. The International Study Group.

  1990cited by this paper
• Measurements of acute cerebral infarction: a clinical examination scale.

  1989cited by this paper
• Hemorrhagic complications associated with the use of intravenous tissue plasminogen activator in treatment of acute myocardial infarction.

  1988cited by this paper
• Update from the Thrombolysis in Myocardial Infarction Trial.

  1987cited by this paper
• Hemorrhagic cerebral infarction--a prospective study.

  1986cited by this paper

• Association Between Hyperacute Blood Pressure Lowering and Outcomes in Patients With Endovascular Thrombectomy

  2026cites this paper
• Long-term systolic blood pressure and cardiovascular risks among patients with ischemic stroke: a register-based cohort study

  2025cites this paper
• Significance of pulse pressure variability in predicting functional outcome in acute ischemic stroke: a retrospective, single-center, observational cohort study

  2023cites this paper
• Admission systolic blood pressure and effect of endovascular treatment in patients with ischaemic stroke: an individual patient data meta-analysis.

  2023cites this paper
• Safety and efficacy of a new modified intravenous recombinant tissue plasminogen activator (rt-PA) regimen in Chinese patients with acute ischemic stroke: A descriptive retrospective cohort study with subgroup-analysis of different rt-PA dose.

  2022cites this paper
• Management of hypertensive crisis: British and Irish Hypertension Society Position document

  2022cites this paper
• Stroke Treatment With PAR-1 Agents to Decrease Hemorrhagic Transformation

  2021cites this paper
• European Stroke Organisation (ESO) guidelines on blood pressure management in acute ischaemic stroke and intracerebral haemorrhage

  2021cites this paper
• Ambiguities in blood pressure management in acute ischaemic stroke.

  2021cites this paper
• European Stroke Organisation (ESO) guidelines on blood pressure management in acute ischaemic stroke and intracerebral haemorrhage

  2021cites this paper
• Optimal Hemodynamic Parameters for Brain-injured Patients in the Clinical Setting: A Narrative Review of the Evidence

  2021cites this paper
• Impact of estimated-weight-base dose of alteplase in acute stroke treatment on clinical outcome.

  2021cites this paper
• Insights into a personalized management of blood pressure in acute stroke

  2021cites this paper
• Blood Pressure Management Following Acute Ischemic Stroke

  2020cites this paper
• Stroke syndromes

  2020cites this paper
• Predictors for the extent of pial collateral recruitment in acute ischemic stroke

  2020cites this paper
• Potential link between post-acute ischemic stroke exposure to hypoglycemia and hemorrhagic transformation

  2020influential citation
• Intracranial Hemorrhage After Reperfusion Therapies in Acute Ischemic Stroke Patients

  2020cites this paper
• Engineered microparticles and nanoparticles for fibrinolysis

  2019cites this paper
• Przegląd czynników ryzyka krwotoku wewnątrzczaszkowego po dożylnym leczeniu trombolitycznym udaru niedokrwiennego mózgu

  2018cites this paper
• Blood Pressure Management for Acute Ischemic and Hemorrhagic Stroke: The Evidence

  2017cites this paper
• Synchronous cardiocerebral infarction in the era of endovascular therapy: which to treat first?

  2017cites this paper
• Hypertension Management in Acute Ischemic Stroke

  2017cites this paper
• A Fall in Systolic Blood Pressure 24 Hours after Thrombolysis for Acute Ischemic Stroke Is Associated with Early Neurological Recovery.

  2016cites this paper
• Recanalization Modulates Association Between Blood Pressure and Functional Outcome in Acute Ischemic Stroke

  2016cites this paper
• Management of High Blood Pressure in Acute Ischaemic Stroke

  2016cites this paper
• Clinical implication of hemorrhagic transformation in ischemic stroke patients treated with recombinant tissue plasminogen activator

  2016cites this paper
• Estimated weight is not a reliable measure for dosing tissue plasminogen activator for thrombolysis in acute ischaemic stroke

  2016cites this paper
• Recanalization Modulates Association Between Blood Pressure and Functional Outcome in Acute Ischemic Stroke

  2016cites this paper
• Recanalization Modulates Association Between Blood Pressure and Functional Outcome in Acute Ischemic Stroke

  2016cites this paper
• Recanalization Modulates Association Between Blood Pressure and Functional Outcome in Acute Ischemic Stroke

  2016cites this paper
• A Four-Year Experience of Symptomatic Intracranial Hemorrhage Following Intravenous Tissue Plasminogen Activator at a Comprehensive Stroke Center.

  2016cites this paper
• Does Prior Antiplatelet Treatment Increase the Risk of Hemorrhagic Transformation and Unfavorable Outcome on Day 90 after Intravenous Thrombolysis in Acute Ischemic Stroke Patients?

  2016cites this paper
• Lower Intraprocedural Systolic Blood Pressure Predicts Good Outcome in Patients Undergoing Endovascular Therapy for Acute Ischemic Stroke

  2016cites this paper
• Acute Thrombolysis in Ischemic Cerebrovascular Disease

  2016cites this paper
• Low-dose intravenous tissue plasminogen activator for acute ischaemic stroke: an alternative or a new standard?

  2016cites this paper
• Acute Blood Pressure Management After Ischemic Stroke

  2016cites this paper
• Early fibrinogen degradation coagulopathy: a predictive factor of parenchymal hematomas in cerebral rt-PA thrombolysis.

  2015influential citation
• Tissue plasminogen activator for acute ischemic stroke: calculation of dose based on estimated patient weight can increase the risk of cerebral bleeding

  2015influential citation
• The ThRombolysis in UnconTrolled Hypertension (TRUTH) protocol: an observational study on treatment strategy of elevated blood pressure in stroke patients eligible for IVT

  2015cites this paper
• The Heidelberg Bleeding Classification: Classification of Bleeding Events After Ischemic Stroke and Reperfusion Therapy.

  2015cites this paper
• Atrial Fibrillation and Cardio-embolic Stroke, Incidence of Haemorrhagic Transformation and Rehabilitation Outcomes

  2015cites this paper
• Intra-arterial Thrombolysis in Acute Ischemic Stroke

  2015cites this paper
• Acute treatment of blood pressure after ischemic stroke and intracerebral hemorrhage.

  2015cites this paper
• The rt-PA for Acute Stroke Protocol

  2015cites this paper
• Elevated pretreatment blood pressure and IV thrombolysis in stroke

  2015cites this paper
• Stroke Unit Management and Revascularisation in Acute Ischemic Stroke

  2014cites this paper
• Intracerebral hemorrhage in patients treated with intravenous thrombolysis for acute ischemic stroke

  2014cites this paper
• Different Doses of Recombinant Tissue-Type Plasminogen Activator for Acute Stroke in Chinese Patients

  2014cites this paper
• Effects of a TAFI-Inhibitor Combined with a Suboptimal Dose of rtPA in a Murine Thromboembolic Model of Stroke

  2014cites this paper
• Endovascular treatment for acute ischemic stroke patients: implications and interpretation of IMS III, MR RESCUE, and SYNTHESIS EXPANSION trials: A report from the Working Group of International Congress of Interventional Neurology.

  2014cites this paper
• Tissue plasminogen activator overdose in acute ischemic stroke patients linked to poorer functional outcomes.

  2014cites this paper
• Plasminogen Activators and Ischemic Stroke: Conditions for Acute Delivery

  2013cites this paper
• Safety and feasibility of intravenous thrombolytic therapy in Iranian patients with acute ischemic stroke

  2013cites this paper
• Caractérisation par IRM précoce de la synergie tPA - inhibiteur du TAFI dans un modèle d'ischémie focale thromboembolique murin

  2013cites this paper
• Nursing, and Council on Stroke Care, Council on Cardiopulmonary and Critical Care, Council on Cardiovascular Statement From the Council on Clinical Cardiology Subcommittee on Acute Cardiac Medication Errors in Acute Cardiac Care : An American Heart Association Scientific

  2013cites this paper
• Trombólise intravenosa para o acidente vascular cerebral isquêmico agudo em um hospital brasileiro, público e acadêmico: caracterização de casuística

  2013cites this paper
• Is there a decreased risk of intracerebral hemorrhage and mortality in obese patients treated with intravenous thrombolysis in acute ischemic stroke?

  2013cites this paper
• Thrombolytic Therapy in the Treatment of Stroke

  2012cites this paper
• Effects of alteplase in the treatment of acute ischemic stroke

  2012cites this paper
• Neurocritical care and periprocedural blood pressure management in acute stroke

  2012cites this paper
• Una cuestión de peso: variabilidad en la estimación del peso del paciente para el cálculo de la dosis de alteplasa IV en el tratamiento del ictus isquémico agudo

  2012cites this paper
• Blood pressure management and evolution of thrombolysis-associated intracerebral hemorrhage in acute ischemic stroke.

  2012cites this paper
• Vascular protection to increase the safety of tissue plasminogen activator for stroke.

  2012cites this paper
• A higher body temperature is associated with haemorrhagic transformation in patients with acute stroke untreated with recombinant tissue-type plasminogen activator (rtPA).

  2012cites this paper
• 62 – Intraarterial Thrombolysis in Acute Ischemic Stroke

  2011cites this paper
• Is the Maximum Dose of 90 mg Alteplase Sufficient for Patients With Ischemic Stroke Weighing >100 kg?

  2011cites this paper
• Microbubbles Improve Sonothrombolysis In Vitro and Decrease Hemorrhage In Vivo in a Rabbit Stroke Model

  2011cites this paper
• Endovascular Therapy for Acute Stroke

  2011cites this paper
• Predictors and Early Outcome of Hemorrhagic Transformation after Acute Ischemic Stroke

  2011cites this paper
• Neurorreparación en la hemorragia intracerebral

  2011cites this paper
• Patient outcomes from symptomatic intracerebral hemorrhage after stroke thrombolysis

  2011cites this paper
• Intravenous Thrombolysis for Acute Ischaemic Stroke: Effective Blood Pressure Control Matters

  2011cites this paper
• Intravenous thrombolytic therapy for acute ischemic stroke.

  2011cites this paper
• Hemorrhage Rates and Outcomes When Using up to 100 mg Intra-Arterial t-PA for Thrombolysis in Acute Ischemic Stroke

  2010cites this paper
• The Significance of Blood Pressure Variability for the Development of Hemorrhagic Transformation in Acute Ischemic Stroke

  2010cites this paper
• Outcomes of Thrombolytic Therapy for Acute Ischemic Stroke in Chinese Patients: The Taiwan Thrombolytic Therapy for Acute Ischemic Stroke (TTT-AIS) Study

  2010cites this paper
• Weight Approximation in Stroke Before Thrombolysis: The WAIST-Study: A Prospective Observational “Dose-Finding” Study

  2010cites this paper
• Interventional Management of Acute Ischemic Stroke

  2010cites this paper
• Fibrinolytic therapy versus craniotomy for anticoagulant-associated intracerebral hemorrhage.

  2009cites this paper
• Perioperative management of acute ischemic stroke: a case report.

  2009cites this paper
• Thrombolytic therapy for acute stroke.

  2009cites this paper
• Chapter 64 – Stroke

  2008cites this paper
• Does Body Weight Influence the Response to Intravenous Tissue Plasminogen Activator in Stroke Patients?

  2008cites this paper
• Predictors of Hemorrhage Following Intra-Arterial Thrombolysis for Acute Ischemic Stroke: The Role of Pial Collateral Formation

  2008cites this paper
• Intracerebral haemorrhage after thrombolysis for acute ischaemic stroke: an update

  2008cites this paper
• Haemorrhagic transformation in acute ischaemic stroke following thrombolysis therapy: classification, pathogenesis and risk factors

  2008cites this paper
• Treadwell and T Robinson classification , pathogenesis and risk factors stroke following thrombolysis therapy : Haemorrhagic transformation in acute ischaemic

  2008cites this paper
• Reperfusion-Associated Hemorrhagic Transformation in SHR Rats: Evidence of Symptomatic Parenchymal Hematoma

  2008cites this paper
• Intracranial Hemorrhage Associated With Revascularization Therapies

  2007cites this paper
• The Management of Blood Pressure After Stroke

  2007cites this paper
• Size Matters: Hemorrhage Volume as an Objective Measure to Define Significant Intracranial Hemorrhage Associated With Thrombolysis

  2007cites this paper
• Correlation Between MMP-3, TIMP-3 Expression and Neuronal Apoptosis After Ischemia -Reperfusion Injury in Rates

  2007cites this paper
• From the Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden

  2007cites this paper
• Alteplase for acute ischemic stroke

  2006cites this paper
• Can Multivariable Risk-Benefit Profiling Be Used to Select Treatment-Favorable Patients for Thrombolysis in Stroke in the 3- to 6-Hour Time Window?

  2006cites this paper
• Optimizing blood pressure in neurological emergencies

  2006cites this paper
• Blood pressure management in patients with acute stroke: pathophysiology and treatment strategies.

  2006cites this paper
• Management of arterial hypertension in patients with acute stroke

  2006cites this paper
• Hemorrhage in the Interventional Management of Stroke Study

  2006cites this paper